Be among trailblazing marketing pros at Brandweek this September 23–26 in Phoenix, Arizona. Experience incredible networking, insightful sessions and a boost of inspiration at ADWEEK’s ultimate brand event. Register by May 13 to save 35%.
NEW YORK If you think that marketing in the drug category is becoming less interesting and more monotonous, you’re right.
A ranking of the most-recalled prescription drug ads shows that such efforts became less memorable for consumers between this year and last, as measured by Nielsen IAG, New York. (Adweek is a unit of the Nielsen Co.)
The ads consumers remembered best in 2007 were executions for Schering-Plough’s allergy drug Nasonex, Takeda’s sleeping pill Rozerem, Schering’s anti-cholesterol brand Vytorin, Pfizer’s anti-cholesterol brand Lipitor and its anti-smoking brand Chantix, and Sepracor’s insomnia med Lunesta.
But midway through 2008, all of those brands have run into controversy or economic difficulties — and several have pulled some or all of their consumer advertising.
What’s
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in